SCHEMBL23327701

SCHEMBL23327701

CNC(=O)Nc1cnn2c(NC)cc(Nc3ccccc3OC)nc12

nearest known ligand 0.56

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ TYK2 P29597 18/20 0.56
▸ STAT3 P40763 1/20 0.56
▸ PDE4D Q08499 1/20 0.48
▸ MAPT P10636 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ JAK1 P23458 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30548451 1.00 TYK2 (0.56) TYK2STAT3PDE4DMAPTSMN1; SMN2
SCHEMBL23327407 0.91 TYK2 (0.48) TYK2STAT3PDE4DJAK1
SCHEMBL30548443 0.91 TYK2 (0.48) TYK2STAT3PDE4DJAK1
SCHEMBL30548454 0.89 TYK2 (0.50) TYK2STAT3
SCHEMBL23327211 0.89 TYK2 (0.46) TYK2STAT3PDE4DMAPTSMN1; SMN2
SCHEMBL30548430 0.89 TYK2 (0.46) TYK2STAT3PDE4D
SCHEMBL23327190 0.89 TYK2 (0.46) TYK2STAT3PDE4D
SCHEMBL23327558 0.89 TYK2 (0.50) TYK2STAT3
SCHEMBL23327472 0.89 TYK2 (0.46) TYK2STAT3PDE4D
SCHEMBL30548435 0.89 TYK2 (0.46) TYK2STAT3PDE4DMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348478-A1 TYK2 PSEUDOKINASE LIGANDS VENTYX BIOSCIENCES, INC. 2023-11-02 — — US disclosed
US-20230348478-A1 TYK2 PSEUDOKINASE LIGANDS VENTYX BIOSCIENCES, INC. 2023-11-02 — — US disclosed
US-11753411-B2 Substituted pyrazolo[1,5-a]pyrimidines as TYK2 pseudokinase ligands VENTYX BIOSCIENCES, INC. (US) 2023-09-12 — — US disclosed
US-11753411-B2 Substituted pyrazolo[1,5-a]pyrimidines as TYK2 pseudokinase ligands VENTYX BIOSCIENCES, INC. (US) 2023-09-12 — — US disclosed
US-20210139486-A1 TYK2 PSEUDOKINASE LIGANDS VENTYX BIOSCIENCES, INC. 2021-05-13 — — US disclosed
US-20210139486-A1 TYK2 PSEUDOKINASE LIGANDS VENTYX BIOSCIENCES, INC. 2021-05-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11753411-B2 Substituted pyrazolo[1,5-a]pyrimidines as TYK2 pseudokinase ligands TYK2, JAK1, JAK2 TYK2 1/4885STAT3 376/4885PDE4D 3275/4885
US-20230348478-A1 TYK2 PSEUDOKINASE LIGANDS TYK2, JAK2, PTK2B TYK2 1/4885STAT3 76/4885PDE4D 4544/4885
US-20210139486-A1 TYK2 PSEUDOKINASE LIGANDS TYK2, JAK2, PTK2B TYK2 1/4885STAT3 76/4885PDE4D 4544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback